The role of artificial intelligence (AI) in drug design has fundamentally shifted from a speculative tool to a central pillar of pharmaceutical research and development (R&D). Sino Biological plays a critical role in this evolving landscape by acting as an essential bridge between computational prediction and experimental truth.
Current AI trends in drug development
According to an industry survey, approximately 81% of pharma organizations now utilize AI in at least one development program1. Predictive modeling and new drug candidate identification and selection are among the major workflows where AI is being applied in pharma R&D (Figure 1). This trend is backed by staggering financial commitments. Large pharma players, such as Pfizer, Takeda, and AstraZeneca, have ramped up their AI investment in recent years, with a particular focus on drug discovery.
The global AI-powered drug discovery market was valued at approximately $3.1 billion in 2025 and is expected to rise to $4 billion in 20262. Top AI-first biotechs include Isomorphic Labs (Alphabet), Insitro, Insilico Medicine, and Recursion2. These key players are leveraging proprietary platforms and high-value collaborations with traditional pharmaceutical companies to reduce development timelines, lower overall costs, and increase the probability of drug candidate success. For instance, Isomorphic Labs signed AI drug discovery deals worth nearly $3 billion with pharmaceutical giants Eli Lilly and Novartis, and another AI startup Chai Discovery announced a partnership with Eli Lilly to accelerate drug discovery using generative design models3,4.
The role of high-throughput expression in AI design
As AI models become increasingly adept at de novo design, the demand for rapid wet lab validation has skyrocketed5,6. Sino Biological’s high-throughput (HTP) antibody production platforms based on dual expression systems–mammalian and cell-free systems–have emerged as transformative tools capable of rapidly producing thousands of AI-designed antibody variants. This enables researchers to move seamlessly from AI-generated sequences to functional antibodies in just days, supporting the fast design-build-test-learn cycles required to refine AI models (Figure 2).
Proven mammalian excellence & rapid cell-free innovation
Traditional mammalian expression systems, such as HEK293 and CHO cell lines, remain the industry gold standard for HTP production of recombinant antibodies, including full-length IgG, VHH, and scFv. Sino Biological leverages deep expertise in HTP gene synthesis, vector construction, and optimized transient antibody expression technology to produce small-scale, high-quality recombinant antibodies, delivering industry-leading throughput (10,000+ antibodies/month) and speed (10 days from gene to antibody). Additionally, immediate access to a catalog of 10,000+ premium recombinant proteins allows for rapid, accurate binding validation of these antibodies, ensuring specificity and high-quality data.
Figure 3. Cell-free protein synthesis process.
Case study of HTP scFv-His and VHH-His synthesis via CFPS: The HTP capability of Sino Biological’s CFPS platform was recently demonstrated in a project involving over 2,000 AI-designed scFv and VHH sequences (Figure 4). The entire library was synthesized and expressed in parallel, followed by binding affinity analysis via BLI. This integrated HTP workflow–bridging production and characterization–facilitated the efficient identification of promising leads with picomolar affinity and the generation of essential data for further pipeline optimization.
Format: 2,000+ scFv-His and VHH-His antibodies
Target: Finished expression and affinity analysis with different target proteins by BLI u464
u464
Early-stage developability profiling is pivotal for de-risking the drug discovery pipeline and streamlining candidate selection8,9. Comprehensive antibody developability evaluation enables the proactive identification and management of potential roadblocks, such as filtering out candidates with suitable binding characteristics but undesirable biophysical properties.
Table 1. Antibody developability assays at Sino Biological.
| Category | Assays |
|---|---|
| Purity | SEC-HPLC/SDS-PAGE |
| Titer | ELISA |
| Solubility | DLS |
| Intact Mass | LC-MS |
| Colloidal Stability | SMAC-HPLC |
| Thermo Stability | nanoDSF/DSC |
| Aggregation | SEC-HPLC/SEC-MALS |
| Self-Association | AC-SINS |
| Hydrophobicity | HIC-HPLC/PAIA-HIC |
| Size Distribution and Aggregation | DLS |
| Target Binding | ELISA/SPR/BLI |
| Affnity Analysis | FACS/SPR/BLI |
| FcγR/FcRn/C1q Binding | SPR/BLI |
| Polyreactivity | BVP/DNA/Insulin ELISA |
| Cell-Based Assay | Assay Specific |
Synchronizing discovery: An Integrated HTP platform for AI-driven innovation
As AI-driven innovation accelerates, aligning experimental throughput with the scale of modern discovery is paramount. This is especially critical as antibody pipelines expand, fueling the demand for seamless HTP expression and parallelized assay workflows.
References
1. Norstella. Assessing the impact of AI transformation on pharma R&D. [Online]. Available at: https://www.norstella.com/assessing-ai-transformation-pharma-rd/ (Accessed: 24 March 2026).
3. Isomorphic Labs. Isomorphic Labs kicks off 2024 with two pharmaceutical collaborations. [Online]. Available at: https://www.isomorphiclabs.com/articles/isomorphic-labs-kicks-off-2024-with-two-pharmaceutical-collaborations (Accessed: 24 March 2026).
4. TechCrunch. From OpenAI’s offices to a deal with Eli Lilly: How Chai Discovery became one of the flashiest names in AI drug development. [Online]. Available at: https://techcrunch.com/2026/01/16/from-openais-offices-to-a-deal-with-eli-lilly-how-chai-discovery-became-one-of-the-flashiest-names-in-ai-drug-development/ (Accessed: 24 March 2026).
6. Li X, et al. Advanced drug delivery systems and AI-driven formulation optimization. Pharmaceutics. 2023; 15(7): 1916. https://doi.org/10.3390/pharmaceutics15071916
7. Wang Y, et al. Monoclonal antibody developability assessment: Challenges and opportunities. Antibodies. 2015; 4(1): 12. https://doi.org/10.3390/antib4010012
9. Nature Biomedical Engineering. Navigating the interface of AI and wet lab automation. Nat Biomed Eng. 2025; 9: 00349-8. https://doi.org/10.1038/s44222-025-00349-8
News – Curated by Amanda Scott, Alias Group Creative
Follow her on Bluesky
Building the Brain Requires Millions of Dangerous DNA Breaks
Scientists discovered that building a healthy brain involves an unexpected step: young neurons routinely break and rapidly repair their own DNA. As the brain develops, newly formed nerve cells must travel through tightly packed tissue [...]
One Tiny Change May Explain How Viruses Jump From Bats to Humans
Scientists found that one tiny genetic change may determine whether a bat virus stays in bats or becomes a human threat. Most infectious disease outbreaks begin when a virus or other pathogen crosses from animals into [...]
Scientists Discover 250+ Genes That Could Lead to New Ways To Prevent Melanoma
The world’s largest study of mole genetics identified hundreds of genes tied to melanoma risk, uncovering potential new drug targets and paving the way for more accurate melanoma screening and prevention. Researchers at QIMR [...]
Breakthrough Diabetes Treatment Reprograms the Immune System
An engineered stem cell therapy reversed new-onset Type 1 diabetes in mice by shifting the immune system away from attacking insulin-producing cells. For more than a century, people with Type 1 diabetes have relied [...]
Taking the world’s temperature: WHO chief spotlights global health emergencies
Taking the world’s temperature on pressing health matters, WHO Director-General Tedros Adhanom Ghebreyesus provided the latest on current global challenges - and successes when it comes to international cooperation. “The outbreaks of hantavirus, Ebola and Marburg all show [...]
Scientists Create Tiny “Mini Livers” That Could One Day Replace Liver Transplants
Engineered tissue grafts could help perform key liver functions and benefit thousands of people living with liver failure. The liver is one of the body’s hardest-working organs, carrying out hundreds of vital jobs, from [...]
NanoMedical Brain/Cloud Interface – Explorations and Implications. A new book from Frank Boehm
New book from Frank Boehm, NanoappsMedical Inc Founder: This book explores the future hypothetical possibility that the cerebral cortex of the human brain might be seamlessly, safely, and securely connected with the Cloud via [...]
Scientists Discover Surprising Way To Help the Brain Recover After Stroke
A new study suggests that strengthening the body’s natural circadian rhythms may help the brain recover after stroke, even when treatment begins days after the injury. Every year, millions of people survive a stroke, [...]
Our books now available worldwide!
Online Sellers other than Amazon, Routledge, and IOPP Indigo Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artifcial Intelligence Global Health Care Equivalency In The Age Of Nanotechnology, Nanomedicine And Artificial [...]
Younger Generations Are Aging Faster – and It May Be Fueling a Surge in Cancer
Younger generations may be aging biologically faster than those before them, and that shift could help explain rising rates of cancer at younger ages. For decades, cancer was viewed largely as a disease of [...]
Using Cannabis Could Raise Your Stroke Risk by 37%, Massive Study Reveals
Large-scale evidence suggests cannabis, cocaine, and amphetamines may directly raise stroke risk, including in younger adults. As recreational drug use becomes increasingly common, researchers are uncovering evidence that its health consequences may extend far beyond [...]
Could Vitamin C Be the Secret to Keeping Your Brain Younger?
Lower vitamin C levels were linked to reduced brain volume and weaker neural connectivity in older adults, suggesting a potential connection between nutrition and brain health. Could a common vitamin help preserve the brain [...]
This Deadly Disease Was Wiping Out Humans 5,500 Years Ago
A new study suggests plague was already a deadly threat 5,500 years ago, striking small hunter-gatherer communities long before cities and agriculture emerged. For centuries, plague has been remembered as the disease that devastated [...]
China closing in but US leads in biotech quality, commercial reach, survey finds
SAN DIEGO, June 22 (Reuters) - China, which now conducts more clinical drug trials, opens new tab than the U.S., still lags in the quality and commercial reach of its biomedical science, according to a recent survey, opens new [...]
New method generates renewable supply of progenitor immune cells
In a paper published in Cell, a USC Stem Cell-led team reports a new way of generating a renewable and expandable supply of the progenitor cells that give rise to macrophages. These immune cells help [...]
Scientists Just Discovered a Cellular Survival System That Was Never Supposed To Exist
A surprising backup pathway allows cells to make a crucial amino acid when their primary machinery fails. For decades, biologists believed cells had only one way to access a molecule they cannot live without. New [...]
